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Abstract

Chronic pain costs up to $635 billion dollars annually and impacts 25.3 million adult U.S.
citizens (Nahin, 2015). Treatment options have typically included opioid medications, which
potentially causes harm with long-term use and has contributed to an epidemic of opioid misuse.
Treatment has expanded beyond monotherapy to include holistic approaches to health, such as
occupational therapy and mental health therapy. The present study sought to evaluate the
effectiveness of group therapy as it is conducted in a rural Oregon clinic using the Quadruple
Aim to measure treatment outcomes (Bodenheimer, & Sinsky, 2014). Participants diagnosed
with chronic pain and placed on an opioid contract by their primary care provider were mandated
to attend four weeks of one hour group therapy which included expectations for healthcare
practices between sessions, and participants were asked to complete a packet of mental health
screeners before and after treatment. Additional financial data regarding participant spending on
medical costs was analyzed. Researchers expected participants’ screener scores to improve and
financial expenditures to decrease overall. Results suggested that group participation was not
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significantly correlated with subjective support of pain, although their medical costs decreased
compared to a matched sample of peers who did not attend group therapy. Ultimately, the
patients and clinic will benefit from ongoing research designed to improve patient satisfaction
while continuing to maintain cost effectiveness. One option discussed to engage in individual
therapy to supplement group therapy. Future research is encouraged to incorporate provider
satisfaction as a means of better utilizing the Quadruple Aim, and to revisit the experimental
design as to include true control and experimental groups thereby allowing variables to be
independently evaluated and stronger conclusions to be drawn regarding the effectiveness of
group therapy.
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Chapter 1
Introduction

Chronic pain is a massive problem facing the United States. It is a daily reality for 25.3
million adults in the United States (Nahin, 2015) and costs the United States $635 billion dollars
annually (Gaskin & Richard, 2012). Broken down farther according to Gaskin and Richard,
“Health care costs due to pain ranged from $261 billion dollars…[and] the value of lost
productivity due to pain ranged from $299 billion to $335 billion dollars annually,” (2012, p.
715. If unattended, chronic pain could cripple the United States financially and drive up the
national debt given that the costs associated with CP are anticipated to grow 1.2% faster than the
United States’ Gross Domestic Product until the year 2025 (Firth, 2017).
This costly phenomenon is not confined to the United States. Research suggests the
prevalence of chronic pain is even greater in Canada, Great Britain, the Netherlands, and Sweden
(Manchikanti, Singh, Datta, Cohen, & Hirsch, 2009). Research conducted by the Global Burden
of Disease, utilizing a systematic analysis of over 250 diseases and conditions that cause
disability worldwide, suggested low back pain and neck pain were two of the leading causes of
disability on a global scale (Vos et al., 2012). Another study led by the Global Burden of Disease
sought to understand and project worldwide spending patterns on healthcare through the year
2040. They found that wealthier countries were projected to increase spending on healthcare at a
level disproportionately greater than lower-income countries (Global Burden of Disease Health
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Financing Collaborator Network, 2017). Given the disparate projected spending patterns, it is
likely that many countries will be unable to efficiently meet the health needs of their population.
Pervasive Impact of Chronic Pain
While it is difficult to identify the precise cost of chronic pain, it is undeniable that
chronic pain is deleterious to the individual’s overall quality of life (Phillips, 2009). Multiple
studies indicate that physical and mental symptoms occurring in tandem with chronic pain are
associated with increased risk for mortality, poorer quality of life and more frequent urgent care
or emergency department visits (Nunes, Flores, Mielke, Thume, & Facchini, 2016). Patients with
these coexisting conditions account for the 45-65% increase in healthcare spending (Thrope,
Ogden, & Galactionova, 2010).
Two of the most common mental health disorders associated with chronic pain are
posttraumatic stress disorder (PTSD) and depression (Outcalt et al., 2015). In addition to a
potentially reciprocal influence on pain, PTSD and major depressive disorder have a significant
impact on overall functioning and quality of life (Outcalt et al., 2015). Additionally, prior
research has suggested that patient mood may be confounded by the impact of chronic pain on
sleep. Pain detracts from sleep and poor sleep in turn contributes to increased pain experiences
(Marty et al., 2008). Not only does chronic pain impact individual’s psychological wellbeing, it
is also implicated in an individual’s physical wellbeing. Research has highlighted that the
combination of chronic pain and clinical depression is a predictive factor for fall risk in geriatric
populations (Eggermont, L., Pennix, B., Jones, R., & Leveille, S., 2012). These findings suggest
that treating pain and concurrent mood related concerns may affect multiple aspects of
biopsychosocial functioning.
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While studies have shown that people with chronic pain who are partnered may fare
better than their single counterparts (Taylor, Davis, & Zautra, 2012), pain has been shown to
negatively impact the partners of those with chronic pain (West, Usher, Foster, & Stewart, 2012).
According to Wethington (2015), chronic pain affects marital quality, intimate relationship
functioning, and overall social integration. Furthermore, adults who report chronic pain also
report poorer sexual functioning and poorer perceived health overall (Wethington, 2015). The
negative repercussions of chronic pain are not reserved for only the patient and their partner.
Family members of people with chronic pain are also impacted. On average they report feeling
powerless, alienated, emotionally distressed and distant as a family unit (West et al., 2012).
Taken together, the systemic impact of chronic pain has increased the urgency to develop
effective treatment for this complex condition.
Treatment Approaches
The healthcare industry is caught between two interrelated crises; the crisis of chronic
pain and the crisis of opioid misuse and overdose (Krashin, Murinova, & Sullivan, 2016). As the
most common allopathic treatment modality for chronic pain, opioid medications are merely
effective in reducing acute pain, though long-term efficacy is lacking (Shaheed, Maher,
Williams, Day, & Mclachlan, 2016). Long-term opiate use is often associated with a range of
side effects, such as nausea, constipation, and tolerance/addiction (Raghavan & Humble, 2011).
Additional studies have found a wide range of chronic health conditions associated with longterm opiate use including hypogonadism, osteoporosis, immune suppression, cognitive
impairment, and hyperalgesia, as well as heightened response reflex to noxious stimuli (2011).
Furthermore, there has been a 124% unintentional drug overdose increase from 1999-2007,

EFFECTIVENESS OF GROUP THERAPY FOR CHRONIC PAIN

4

largely due to prescription-related opioid overdoses (Okie, 2010). This increase in opioid-related
deaths has led to policy makers enforcing stringent prescribing practices, as observed in standard
care practices within the State of Oregon. Specifically, patient morphine equivalency doses
(MED) can no longer exceed 100-milligrams within five years in the state of Oregon (2010). In
an observation that pre-dates the current opioid misuse epidemic, Henry McQuay (2008)
observed that chronic pain is low on political priority lists and deserves more attention from our
elected officials. He continued to say chronic pain puts people “at the bottom of the pile.”
making the need evident for professional advocacy in order to attain a “fairer share of the
medical resource cake,” (2008, p. 38).
Multidisciplinary approaches have been shown to reduce costs and result in a higher
quality of care for patients with chronic pain (Crosson, 2009). Research in the last 10 years has
clearly shown that chronic pain is best treated using an interdisciplinary approach, including
behavioral health, pharmacologic and nonpharmacologic self-management interventions
(Tompkins, Hobelmann, & Compton, 2017). Given the myriad of mental health symptoms
associated with chronic pain, it follows that behavioral health services are an important
component of the interdisciplinary chronic pain treatment team. Behavioral health treatments
typically involve interventions by a behavioral health consultant who has been trained with a
cognitive-behavioral therapy (CBT) modality (Jensen, 2011). Research conducted by Possemato
et al. (2018) relevant to a systemic approach in treating primary care has shown the efficacy of
Primary Care Behavioral Health (PCBH) services, including higher levels of patient engagement
in care, improved patient satisfaction, and shorter wait-times. While it is known that
collaborative care models improve mental and physical health, such as chronic pain, the
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effectiveness may vary (Beck et al., 2018), posing a problem for clinicians. In contrast, there is
consistent evidence to support collaborative care models as potentially cost-effective treatment
approaches for people with mental and physical co-existing conditions including chronic pain
(Cemacho et al., 2018). Towards that end, one relevant domain of cost savings is the reduced
expenditure in out-patient mental health specialty services that occurs when patients receive
integrated behavioral health services within the primary care clinic (Leung et al., 2017).
Non-pharmacological treatments include alternative medicine and behavioral health
interventions, and are often referred to as complementary and alternative medicine (CAM)
therapies. Alternative medicine approaches consider massage therapy, physical therapy, and
acupuncture viable treatment options (Vickers et al., 2012). The National Center for
Complementary and Integrative Health (NCCIH) divides CAM into two categories, mind and
body therapies (e.g., yoga, exercise, relaxation techniques) and natural products (e.g., herbs and
vitamins; NCCIH, 2017). Given comorbid health issues arising from chronic pain, as well as
strides to emphasize holistic health approaches, other fields (e.g., occupational therapy, physical
therapy, and psychology) are tantamount in providing optimal care.
To further complicate treatment for chronic pain, there are pain presentations not
responsive to first line treatments, such as systemic drug delivery options and physical therapy.
When conventional methods are ineffective toward treating chronic pain, it is considered
“refractory pain,” (Chaverneff, 2016). According to Chaverneff, spinal cord stimulation and
interventional therapy (IT) may be effective treatments for refractory pain (2016). Interventional
therapy is an invasive procedure in that medications are directly injected to areas of concern,
theoretically lessening the potential for overdose (Chaverneff, 2016). However, other studies

EFFECTIVENESS OF GROUP THERAPY FOR CHRONIC PAIN

6

have called the efficacy of interventional therapy into question, proposing that IT effects are
uncertain given the inborn risk and high cost of interventional therapy (Ko & Kim, 2012, June).
Another option to treat refractory pain may be transcranial magnetic stimulation. According to
Cheng (2013), transcranial magnetic stimulation may be able to reduce pain transmission across
the spinal cord (2013). Other studies have shown that 20 minutes of transcrainial magnetic
stimulation increases pain thresholds in some participants (Taylor et al., 2013). The relatively
high cost and variability in outcome highlights the need for multi-disciplinary treatment that are
more affordable and accessible.
The “Triple Aim” as defined by McCarthy and Klein (2010) is a policy designed to
enrich patient experience of care with respect to quality and satisfaction, the overall health of the
general population and the cost of care. Financial expenditures and patient health are two integral
components of the “Triple Aim,” (McCarthy & Klein, 2010). More recently, pundits in the
healthcare community have advocated for the addition of a fourth component, provider
satisfaction. The goal of the fourth component is “to minimize physician burnout,” thereby
ensuring a stable workforce as chronic health conditions continue to rise. Including the fourth
component is particularly relevant for providers treating patients with chronic pain. Research has
highlighted that treating chronic pain induces feeling of frustration and powerlessness in both
provider and patient as it is often a recalcitrant condition. As such, opting for the Quadruple Aim
in lieu of the Triple Aim (Bodenheimer, & Sinsky, 2014) may be particularly relevant for
providers treating patients with chronic pain. Ultimately, the Quadruple Aim initiative provides a
framework to evaluate the effectiveness of multidisciplinary approaches to chronic pain.
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Current research supports the use of group therapy, in addition to individual therapy, as a
treatment modalities for chronic pain (Feng & Catlin, 2016). One group therapy study indicated
fewer depressive symptoms and less pain interference of their normal activity after treatment
(Feng & Caitlin, 2016). According to Alizadehfard (2012), chronic pain participants who
completed long-term group therapy were better able to find adaptive solutions that minimized
their typical recurrent pain behaviors. In addition, existential psychology-based group therapies
were also found to be efficacious, as “life review group therapy” for elderly chronic pain
sufferers’ resulted in significant improvements on pain-related questionnaire scores
(Alizaderfhad, 2012).
People living in rural areas experience additional barriers in accessing treatment for
chronic pain, including limited general and specialty providers, transportation and limited
financial resources as compared to similar populations living in urban areas. While the efficacy
of cognitive behavioral therapy is well-documented toward treating common mental disorders,
access to treatment itself is largely insufficient (Salomonsson et al., 2018). Access limitations
make treatment in rural settings even more difficult, as a result, rural residents are more likely to
rely solely on their primary provider for pharmacological treatment and neglect self-management
interventions. The overreliance on PCPs in rural populations is likely a function of having
limited access to a network of formally trained providers with expertise in managing pain
(Mezei, & Murinson, 2011) in conjunction with the proclivity for rural residents to be prescribed
opioids at higher rates than non-rural residents (Prunuske et al., 2014). This has led to a
significant disparity in the use of self-management techniques for rural populations (Eaton et al.,
2018). A possible solution to increase access may be found in guided self-help (GSH) cognitive
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behavioral therapy. GSH cognitive behavioral therapy is a method in which patients meet faceto-face with a clinician for an initial appointment then may have as few as zero face-to-face
appointments thereafter, using telehealth instead. GSH cognitive behavioral therapy boasted
comparable disorder remission rates in 6- and 12-month follow-ups (Salomonsson et al., 2018).
Other studies have found similar results, supporting the effectiveness of digital behavioral health
programs in primary care settings. Yu, Szigethy, Wallace, Solano, and Oser (2018) found that
digitally delivered therapy interventions are associated with reductions in anxiety-related
symptoms, thereby improving access to patients in need.
Program Evaluation: The EPIS Model
Especially within the context of the Quadruple Aim, it is incumbent on healthcare
providers to systematically develop and assess all patient treatment interventions and programs.
There are many methods of evaluating the effectiveness of programs, particularly within primary
care settings. One such method is the EPIS model. EPIS stands for Exploration, Preparation,
Implementation, Sustainment (Aarons, Hurlburt, & Horwitz, 2011). Per Aarons et al. (2011),
Exploration refers to the process of considering what evidence-based practices might best solve
the identified problem, while considering challenges to the outer and inner contextual factors,
Preparation refers to planning the logistics of how to include the selected practice into the
existing system, Implementation refers to carrying out the planned intervention, allowing
implementers opportunity to discern if there are major areas of concern regarding the
intervention, and Sustainment refers to the ongoing monitoring of the program in terms of quality
and finances. The California Evidence-Based ClearingHouse for Child Welfare has adopted the
EPIS model as its primary evidence based implementation framework. Studies have shown that
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the utilization of the EPIS model improves care for vulnerable populations as it is applied to
outer service systems and inner organizational contexts simultaneously (Becan et al., 2018). The
current study used the EPIS model to effectively measure and implement evidence-based
changes in an existing system.
Present Study
Per McQuay (2008, p. 41), “No one thing will improve this (chronic pain) situation. We
need more and better basic research.” The purpose of the current study was to evaluate the
effectiveness of the Pain Pathway Program developed and implemented within a small primary
care practice in a rural Oregon county with the hopes of improving outcome for patients with
chronic pain. The Pain Pathway Program is the clinic’s response to the ineffectiveness and
increasing epidemic of opioid misuse in Oregon. The treatment program mandated patients who
were prescribed opioids to attend four two-hour group therapy sessions over the period of four
weeks. The sessions reviewed theories of pain, pain’s impact on relationships, coping strategies,
and associated relaxation techniques. The current study evaluated the effectiveness of this
program with a dual focus on patient outcome and financial expenditure.
Researchers expected results to converge with the current body of literature in that group
therapy is effective at improving patient health and decreasing patient fiscal expenditures. For
the present study, the following hypotheses were tested:
Hypothesis 1: Patients who completed the Pain Pathway Program will have improved
healthcare outcomes compared to the comparison group
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Hypothesis 2: Patients who completed the Pain Pathway Program will spend less money
on treatment and medical expenses than their peers who did not complete or attend the Pain
Pathway Program.

EFFECTIVENESS OF GROUP THERAPY FOR CHRONIC PAIN

11

Chapter 2
Methods
Participants
The current study used archival data from approximately 850 chronic pain patients who
sought medical attention for chronic pain in one medical clinic within a rural county in Oregon
(94% Caucasian, 3% Latino/Latina, 3% other; average age of participants was 60.53 years old).
Participants rated their pain on a scale ranging from 1-10 (1 = little to no pain, 10 = severe pain).
The average pain rating was 6.38 (SD = 1.74) and participant pain “at its worst” within 24 hours
of completing the screener was 4.75 (SD = 1.72). However, one-third of participants reported
their pain “at its worst” as 7/10. Pain was most commonly reported on the back, knees and legs.
The treatment group (i.e., participants who completed the pain pathway and did pre- and postscreeners) was comprised of 15 people. Financial data regarding healthcare spending habits was
gathered for 12 of those 15 people. Insurance claims data was collected for an additional 15
people who did not complete the requisite group therapy in order to supplement a control group
in terms of spending patterns. The control group (i.e., the group that did not complete the four
group therapy sessions and associated screener packets) was 786 people. This group was used to
ensure the treatment group was representative of the larger pain patient population with respect
to age, gender, morphine equivalent dose (MED), and ethnicity. There were no specific
exclusionary criteria once patients were admitted into the Pain Pathway. This research project
was approved by the Human Subjects Review Committee of George Fox University, Newberg,
OR.
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Materials
Participants completed a combination of screeners, typically upon entering the pain
pathway. The screeners examined within the pain packet are the Patient Health Questionnaire
(PHQ-9), Generalized Anxiety Disorder 7-item scale (GAD-7), Brief Pain Inventory-Short Form
(BPI), and Physical Functional Ability Questionnaire (FAQ-5).
The Patient Health Questionnaire. The Patient Health Questionnaire (PHQ-9) assesses
depression using a 9-point Likert scale. This measure has been shown to accurately predict
depression, as evidenced by 7.0-13.6 percent increase in the odds of depression among people
with elevated PHQ-9 scores (Kroenke, Spitzer, & Williams, 2001). For the present study, not all
items were collected for the PHQ-9 and thus the data was prorated for analysis purposes. See
Appendix A.
The Generalized Anxiety Disorder Screener. The Generalized Anxiety Disorder
Screener (GAD-7) is used to assess anxiety using a 7-point Likert scale. The GAD-7 has a 0.83
test-retest reliability and significant concurrent validity compared with the Beck Anxiety
Inventory (r = .072; Lowe et al., 2008). For the present study, not all items were collected for the
GAD-7 and thus the data was prorated for analysis purposes. See Appendix B.
The Brief Pain Inventory-Short Form (BPI). The Brief Pain Inventory-Short Form
(BPI) is a measure used to assess pain levels. The nine questions on the BPI evaluates severity of
pain, the impact of pain on daily function, the location of pain, pain medications, and the amount
of pain relief in the past 24-hours. The BPI has acceptable internal consistency, construct
validity, criterion validity, and high test-retest reliability (Stanhope, 2016). For example, internal
consistency reliability (Cronbach's α) was greater than 0.80 for the BPI according to Kapstad,
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Rokne, and Stavem (2010). For the present study, not all items were collected for the BPI and
thus the data was prorated for analysis purposes. See Appendix C.
The Physical Functional Ability Questionnaire (FAQ5). The Physical Functional
Ability Questionnaire (FAQ5) is a 5-question tool measuring a participant's functioning in
activities of daily living (e.g., walking up a set of stairs without assistance). Participants rank
from 0-4 how impaired they are in the following domains: self-care, chores/social activities,
walking/stairs, lifting, and work; scores of zero infer complete impairment and four’s indicate
lack of impairment. Patient responses were calculated to extrapolate an approximate percentage
of impairment. The FAQ5 appears to have reasonable face validity as all questions directly
pertain to participant’s functioning. For the present study, not all items were collected for the
FAQ5 and thus the data was prorated for analysis purposes. See Appendix D.
Pain risk numbers. The Pain Risk Number is an in-house measurement of the likelihood
of someone abusing prescription opioid medications. It is a weighted number out of 10 computed
by a computer algorithm. Quarterly urine analysis, previous substance use history, current
alcohol use, presence of a sleep apnea diagnosis, current or previous prescriptions of other
opiates, methadone or benzodiazepines, and other previous or current psychiatric diagnoses are
factors used in the calculation of an individual’s pain risk number. These numbers were
calculated by staff members and pain specialists within the clinic.
The morphine equivalent dose. The Morphine Equivalent Dose (MED) is a numerical
measurement against which all opioids can be compared in terms of pain relief. Understanding
MED’s allows doctors and patients to measure opioid doses as either effective or excessive, in

EFFECTIVENESS OF GROUP THERAPY FOR CHRONIC PAIN

14

addition to aiding in decision making processes when considering transitioning from one opioid
to another.
Financial claims data. Financial claims data was provided to the researchers by the
health plan’s Business Intelligence Specialist (see Procedure), and researchers analyzed the
amount of money patients spent on office visits, inpatient stays, outpatient services, emergency
department visits, lab costs, and overall facilities costs. In order to appropriately compare means
before and after treatment, data was pulled six months prior to a patient’s entry into the Pain
Pathway and then for the six-month period after they completed the requisite four group therapy
sessions. Similarly, a control group was established by pulling six months of claims data for
patients who met with a pain coordinator but did not attend the requisite group therapy.
Procedure
Participants signed an informed consent acknowledging their electronic health
information and responses to the pain screener packets may be used for research purposes.
Participants who agreed to the informed consent policy then met with a Pain Coordinator to
assess their risk of abusing opioid medications. At this time, the Pain Coordinator provided
participants the pain screener packets and divided them between “Pain High” and “Pain Low”
groups. Participants were placed into the Pain High group if they met the following criteria:
prescription is equal to or greater than 40 MED, use of methadone and/or benzodiazepines,
history of psychological diagnosis (past or present), and sleep apnea. Participants were placed in
the Pain Low group if they met the following criteria: prescription is an MED score lower than
40 and no other reported risk factors. Participants were placed in the “Pain Observation” group if
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they met the following criteria: an MED score of 15 or less, managed psychological diagnosis
(i.e., in treatment/remission), managed sleep apnea, and no methadone or benzodiazepine use.
Participants in the Pain High category were required to attend four group psychotherapy
sessions where they learned about chronic pain, current theories on pain, pain’s impact on
relationships, coping strategies, and relaxation techniques. Pain Low participants were given the
option to engage in the Pain Pathway groups. All participants (i.e., both Pain High and Pain
Low), were required to meet with a Pain Coordinator quarterly the entire time they were
prescribed opioids. The Pain Coordinator provided the same measures from the initial pain
screener packet to gather post-group data in order to measure the effectiveness of group therapy
after participants completed their fourth and final group therapy session. To collect participant
healthcare expenses, researchers gathered patient insurance policy numbers on an encrypted
spreadsheet. Then researchers hand delivered the encrypted data to the Business Intelligence
Specialist of the health plan who extracted specific participant expenses from a database.
Participants were excluded if they were not willing to cease substance or alcohol use, or if they
were rated as Pain Low and elected to abstain from the Pain Pathway.
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Chapter 3
Results

The average age of participants who completed the pain pathway and screeners, aka the
treatment group, (M = 59.85, SD = 13.05) was comparable to the mean age of participants
within the comparison group (M = 58.44, SD = 18.02). In other words, the two groups were
statistically homogenous in terms of age [F(1,844) = .429, p = .51]. Similarly, participant MED
(t(13.37) = -0.63, p = .05) and Pain Risk (t(68) = 0.39, p = .70) was virtually indistinguishable
between the treatment and comparison groups. See Tables 1 and 2.

Table 1
Patient Demographics
Measure

Treatment

Comparison

x̅

SD

x̅

SD

Age

59.85

13.05

58.44

18.02

MED

30.23

22.85

48.89

36.30

2.18

1.17

1.78

1.30

Pain Risk
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Table 2
Patient Demographics Part 2
Demographic data

Treatment

Gender

Male
Female

Ethnicity

Caucasian
Latino(a)
Other

3
9
10
2
3

Comparison
4
11
13
1
1

An independent samples t-test was calculated to ensure that the participants whose
financial data was collected were equitable between groups in terms of age, MED, and Pain Risk.
Findings suggested no significant difference in terms of age for patients who attended the Pain
Pathway (M = 49.69, SD = 13.57), and those who did not (M = 46.38, SD = 11.08); t(25) =
-.669, p = .491). Levene’s test indicated equal variances (F = .39, p = .538) and thus the degrees
of freedom were not adjusted. There was no significant difference in terms of MED for patients
who attended the Pain Pathway (M = 30.23, SD = 25.85) and those who did not (M = 48.89, SD
= 36.30); t(18) = 1.342, p = .20. Levene’s test indicated equal variances (F = .69, p = .42) and
thus the degrees of freedom again were not adjusted. Lastly, there was no significant difference
in terms of Pain Risk for those who attended (M = 2.18, SD = 1.17) and those who did not (M =
1.78, SD = 1.30); t(18) = -.731, p = .47. Levene’s test indicated equal variances (F = .73, p = .41)
and thus the degrees of freedom were not adjusted. Said another way, the comparison and
treatment groups were equitable with one another in terms of age, MED, and Pain Risk.
Similarly, a Chi-Square test of independence was calculated comparing the frequency of
distribution of gender and ethnicity between the treatment and comparison groups. No
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relationship was found between gender and completion of the Pain Pathway in this study, X2(1) =
.01, p = .922. Again, no relationship was found between ethnicity and the participants of this
study, X2(2) = 1.41, p = .494. These findings suggested that ethnicity and gender were equally
represented in both groups.
Results on pre and post screeners were analyzed using a paired samples t-test. Not all
items were collected from the screeners, and therefore data for the PHQ-9, GAD-7, BPI, and
FAQ-5 were prorated. Results are displayed in Table 3.

Table 3
Patient Health Screeners
Measure
Pre x̅

Post x̅

Pre SD

Post SD

t

d’

p

PHQ-9

4.14

8.73

3.26

5.07

-2.19

-.69

.06

GAD-7

3.15

10.85

3.48

6.58

-3.02

-.95

.02

FAQ-5

71.88

68.75

13.26

0.00

0.33

.24

.79

BPI

3.76

5.26

2.01

0.49

-2.15

-.68

.06

MED

30.23

25.27

25.85

21.06

1.38

.42

.20

Pain Risk

2.00

2.59

1.21

1.39

0.18

.21

.70

Scores on the PHQ-9 resulted in no significant change after treatment, t(9) = -2.19, p =
.06, however the effect size for the difference between means was moderate, d’ = -.69. There was
a significant increase in anxiety scores, reflected on the GAD-7, after treatment, t(9) = -1.93, p =
.02, and a large effect was observed, d’ = -.95. Scores on the FAQ-5 underwent no significant
change after treatment, t(1) = .33, p = .79, however a small effect size was observed, d’ = .24.
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After treatment, scores on the BPI did not significantly change, t(9) = -2.15, p = .06, and a
medium effect was observed, d’ = -.68. There was no significant change in patient MED’s after
treatment, t(10) = 1.38, p = .20, and a small effect of time was observed before treatment and
after treatment, d’ = .42.
Non-significant differences in scores were observed regarding patient Pain Risk before
group therapy (m = 2.00, sd = 1.21) and after group therapy (m = 2.59, sd = 1.39). Additionally, a
small effect was observed; t(68) = 0.18, p = .70, d = .21.
A 2 (times) x 2 (groups) x 6 (cost centers) repeated measures ANOVA was calculated to
quantify the effect of time, group attendance, and cost centers on money spent for pain
management. The cost centers were: total costs, office visit, outpatient, emergency department,
laboratory, and facilities. Sphericity was met for all analyses. Due to the small sample sizes and
associated low power, the ANOVA results will not be reported and eta2 will be reported in
addition. The results are displayed in Table 4.
No main effect of group was observed, F(1,25)=2.87, p= .10. No significant main effect
of time was observed, F(1,25)= 2.13, p= .16, and no significant interaction was observed of time
and group, F(1,25)= 3.55, p= .07. However it should be noted the effect sizes of these factors and
their interactions are all moderate in size.
Although the increase in total costs for the comparison group was not significant (t(14) =
-1.99, p = .07; d = .52), a moderate effect was observed. Interestingly for the treatment group,
whose findings did not boast significance as well (t(11) = .55, p = .59; d = .15), no effect was
observed. In other words, participants who did not attend group therapy had large increases in
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Table 4
Cost Centers for Treatment and Comparison Groups
Treatment group
Measure

Mean

SD

Total pre

973.75

1530.70

Total post

686.99

1250.43

Office pre

570.88

Office post

d’

Comparison group
Mean

SD

925.36

1038.19

3189.60

4388.95

1102.86

619.39

708.58

332.36

520.39

892.92

961.62

Outpatient pre

25.32

66.20

44.34

70.42

Outpatient post

8.30

22.44

252.93

443.82

ED pre

91.58

175.68

4.13

16.00

ED post

45.10

111.85

94.36

195.62

Lab pre

49.27

83.22

118.38

113.21

Lab post

51.66

79.49

96.66

129.52

Facilities pre

236.70

338.05

139.11

239.40

Facilities post

210.93

519.23

1731.23

3266.39

.15

p

.59

d’

p

.52

.07

η2

.28

.05

.058

.16

.673

.01

.09

.11

.15

.08

their expenditures regarding healthcare. However, participants who attended group therapy had
little to no increase in expenditures.
Three paired samples t-tests were used to make post hoc comparisons between office visit
spending patterns. The comparison group’s spending patterns were evaluated at the time of their
entry into the pain pathway (M = 619.39, SD = 708.58) and six months after their entry (M =
892.92, SD = 961.62) and the experimental group’s spending patterns were evaluated for the six
months before entering the pain pathway (M = 570.88, SD = 1102.86) and six months after
completing the regiment (M = 332.36, SD = 520.39). There was not a significant main effect of
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2
group (treatment and comparison), F(1,25) = 1.23, p = .28, η = .05. The eta2 indicates that this

is a small effect. A second Paired samples t-test indicated no main effect was found with respect
to time, F(1,25) = .009, p = .93, η2 = .000. A third paired samples t-test indicated a small
interaction between time and group, F(1,25) = 1.96, p = .174, η2 = .07.
Three paired samples t-tests were used to make post hoc comparisons between outpatient
spending patterns. The comparison group’s expenditures were evaluated at the time of their entry
into the pain pathway (M = 44.34, SD = 70.42) and six months after their entry (M = 252.93, SD
= 443.82) and the experimental group’s expenditures were evaluated for the six months before
entering the pain pathway (M = 25.32, SD = 61.87) and six months after completing the
regiment (M = 8.30, SD = 22.44). A first paired samples t-test indicated that there was not a
significant difference between groups, however a large main effect was found with respect to
group attendance, F(1,25) = 3.96, p = .058, η2 = .16. A second paired samples t-test indicated a
lack of significant difference between the groups, however a moderate main effect was found
with respect to time, F(1,25) = 2.17, p = .15, η2 = .08. A third paired samples t-test indicated a
lack of significant difference between the groups, however a moderate interaction was found
with respect of time and group, F(1,25) = 3.01, p = .10, η2 = .11. Secondary analyses were ran
to calculate the exact trend of each group’s reaction to the large interaction between groups.
Results, via a paired samples t-test, suggest that the control group before and control group after
reacted to the large interaction differently (t(17) = -0.17, p = .86). An independent samples t-test,
whose variances were assumed (F = .08, p = .16), suggested that the effect sizes support that the
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control and experimental groups responded to the large interaction of group differently as a
function of group attendance (t(19) = 1.45, p = .16).
Three paired samples t-tests were used to make post hoc comparisons between
emergency department costs. The comparison group’s expenditures were evaluated at the time of
their entry into the pain pathway (M = 4.13, SD = 16.00) and six months after their entry (M =
94.36, SD = 195.62) and the experimental group’s expenditures were evaluated for the six
months before entering the pain pathway (M = 91.58, SD = 175.68) and six months after
completing the regiment (M = 45.10, SD = 111.85). A first paired samples t-test indicated that
there was not a significant difference between the control and experimental group and no main
effect was found with respect to group attendance, F(1,25) = .183, p = .673, η2 = .01. A second
paired samples t-test indicated a lack of significant difference between groups, however a
moderate small effect was found with respect to time, F(1,25) = .46, p = .51, η2 = .02; a third
paired samples t-test indicated a lack of significant difference between the groups, however a
large interaction was found with respect of time and group, F(1,25) = 4.44, p = .045, η2 = .15.
Three paired samples t-tests were used to make post hoc comparisons between lab costs.
The comparison group’s spending patterns were evaluated at the time of their entry into the pain
pathway (M = 118.38, SD = 113.20) and six months after their entry (M = 96.67, SD = 129.52)
and the experimental group’s spending patterns were evaluated for the six months before
entering the pain pathway (M = 49.28, SD = 83.22) and six months after completing the
regiment (M = 51.66, SD = 79.49). A first paired samples t-test indicated that there was not a
significant difference between groups, however a moderate main effect was found with respect to
group attendance, F(1,25) = 3.08, p = .09, η2 = .11. A second paired samples t-test indicated a
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lack of significant difference between the groups, however a small main effect was found with
respect to time, F(1,25) = .15, p = .702, η2 = .01. A third paired samples t-test indicated a lack
of significant difference between the groups, however found no interaction of time and group,
F(1,25) = .22, p = .63, η2 = .009.
Three paired samples t-tests were used to make post hoc comparisons between facilities
costs. The comparison group’s spending patterns were evaluated at the time of their entry into
the pain pathway (M = 139.11, SD = 239.40) and six months after their entry (M = 1731.23, SD
= 3266.39) and the experimental group’s spending patterns were evaluated for the six months
before entering the pain pathway (M = 236.70, SD = 338.05) and six months after completing
the regiment (M = 210.93, SD = 519.23). A first paired samples t-test indicated that there was
not a significant difference between groups, however a moderate main effect was found with
respect to group attendance; F(1,25) = 2.18, p = .15, η2 = .08. A second paired samples t-test
indicated a lack of significant difference between the groups, however a moderate main effect
was found with respect to time, F(1,25) = .2.65, p = .116, η2 = .10. A third paired samples t-test
indicated a lack of significant difference between the groups, however found a moderate
interaction of time and group, F(1,25) = 2.83, p = .11, η2 = .10.
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Chapter 4
Discussion

The present study sought to evaluate the effectiveness of group therapy as a treatment for
chronic pain as conducted at a medical clinic in rural Oregon. Participants completed a
combination of screeners before and after completing four separate group therapy sessions.
Additionally, their financial expense patterns were recorded and analyzed before and after
completing the group therapy requirements. The first hypothesis tested predicted patient
screeners would show improved overall quality of health after group therapy. The second tested
hypothesis predicted that participants who attended the Pain Pathway would spend less money
on medical care after completing the program. Scores on most health screeners showed a trend
toward worsening after treatment, however these changes cannot be ruled out due to random
chance. Scores on an anxiety measure were significant and showed worse anxiety symptoms
after treatment. This conclusion contradicts current research regarding the effectiveness of group
therapy and converged with research acknowledging the high degree of variability in
multidisciplinary settings. Secondly, patient MED, Pain Risk numbers, and health screener
scores did not result in significant change after treatment for the treatment group. Findings
illustrated decreases in spending over time which converged with the current literature stating
that group therapy and PCBH decrease financial burden for patients, particularly in rural settings.
As measured by the Triple Aim, this program does not significantly influence patient health
screeners and thereby does not bolster patient health outcomes. As such, researchers failed to
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reject the null hypothesis. However, more data will be needed to draw decisive conclusions given
the discrepancy between patient self-report measures and financial data.
As stated, patient health screeners appeared to be associated with, although lack of
statistical significance would indicate the necessity to increase power or sample size, worse
scores after treatment overall. That said, according to the effect sizes, the symptoms assessed
PHQ-9 and BPI worsened by a moderate degree (effect sizes go here) after treatment, the
symptoms assessed by the GAD-7 worsened by a large degree (effect sizes go here), and the
symptoms assessed by the FAQ-5 worsened by a small degree. Moreover, according to effect
sizes scores, on the PHQ-9 went from none to mild after treatment, GAD-7 scores went from
“none” to moderate, and scores on the BPI were within the mild range prior to treatment and
were in the moderate range after treatment, according to the cutpoints for the BPI as posited by
Kapstad, Hanestad, Langeland, Rustoen, and Stavem (2008). This study failed to reject the null
hypothesis regarding patient health outcomes as represented by health screeners.
The lack of support for the effectiveness of the group may have been influenced by a
negative contagion in the group setting. In other words, since participants may have been
resentful they were mandated to attend treatment to receive their previously prescribed pain
medication. This resentment may have been exacerbated by the broad directive that mandated
providers reduce the MED prescription regardless of patients’ demonstrated responsibility in
using medication. Screener results were not consistent with the current body of literature, nor
what researchers expected to find regarding group therapy as a largely positive influence in
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patient health outcomes. Again, the small quantity of patients who attended group therapy and
completed post-treatment screeners may have contributed to the lack of significant results.
MED likely decreased as a function of statewide policy, explaining the observed small
effect of time on MED decreases. This mandatory decrease in medication dose, while enhancing
patient safety, likely contributed to patient dissatisfaction illustrated via other measures (e.g.,
scores on PHQ-9, GAD-7, etc.). Although at a first glance, the program may not be seen as
positively affecting patient experience, it is important to note that patient’s mood or perception
of function did not decrease even as their MED was decreased. Some patients with chronic pain
may catastrophize that if their pain medication is reduced, they will experience a significant
increase in mental health symptoms and pain interference. The expected increase in impairment
simply did not happen in this group. Given the quasi-experimental nature of the design, it is
impossible to determine if the symptom stabilization in the face of opioid reduction was due to
group participation or gradual adjustment to decrease in MED. Ongoing stabilization may be the
first step on a gradual improvement in mood and functioning as patients are tapered to lower
MED. It is possible that patient satisfaction will increase as populations become more
accustomed to the new prescription practices and alter medication expectations accordingly.
The cost centers examined for this study were overall costs, office visits, outpatient,
emergency department, lab, and facilities. Three cost centers improved for people who
completed the program and three cost centers remained the same after treatment for those who
completed the program. This is in contrast to the comparison group, where financial costs
regardless of cost centers. In other words, patients who did not attend the Pain Pathway had
significant increases in financial costs in all domains whereas patients that did attend had little or
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no increase in financial costs. These financial differences are particularly notable because the
participants who were mandated to treatment were selected because their higher risk scores. So,
when the highest risk patients showed a decrease in medical claims as compared to the lower risk
tau group, it raises the consideration that a group treatment for patients with chronic pain may
have the potential to impact medical costs. Taken together, group therapy is associated with
decreasing spending patterns on pain. Therefore researchers rejected the null hypothesis
regarding patient spending.
Limitations
This study was most limited by the small sample size and lack of a true control group,
given that patients were mandated into the treatment group. The sample size and lack of
randomly assigned treatment intervention prevented researchers from drawing direct and
generalizable causal conclusions regarding patient wellness as a function of attending group
therapy. Other limitations included proration of test scores, standard pitfalls of subjective patient
self-report, time variability in screener completion, and potentially negative contagion
influencing patient health screener scores.
Recommendations for the Clinic
Perhaps most relevant for sustaining the gains made by the Pain Pathway, research and
program evaluation models has shown that clinics are more likely to have successful outcome,
and more engagement in sustaining the related processes when they have a clear implementation
plan to launch a new program (Moise et al., 2018). As such, the clinic would likely benefit from
having a designated care manager for pain patients while being open to renegotiating their
policies regarding pain care in response to ongoing program assessment. The program may also
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benefit from reducing the number of screeners and pages overall in the pain packets. This
reduction would ideally minimize frustration felt by participants of the Pain Pathway that are
already distressed. In addition, staff could encourage participants to engage in individual therapy
to supplement material covered in group therapy and more importantly treat and monitor any
significant mood changes. Lastly, clinicians could caution clients that they may not experience
immediate improvement as they progress through the stages of group therapy and that continuing
to experience some pain does not necessarily equate to their condition worsening.
Recommendations for Future Studies
Future researchers would benefit from redesigning the experiment so that it included true
control and experimental groups via random selection and assignment. As the field moves more
toward the Quadruple Aim, assessing provider satisfaction as well as patient outcome and patient
satisfaction would strengthen conclusions regarding the potentially positive impact of a group
intervention for patients with chronic pain.
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Appendix E
Curriculum Vitae

William Summers
3902 Polly Ave, Apt# B10, Yakima WA, 98901
254.231.1931
WLSummers1991@gmail.com

Education
PsyD George Fox University, Newberg, OR
Anticipated Graduation May 2020
Dissertation: Studying the effectiveness of group therapy on chronic pain: A program
evaluation (Defended on May 8th, 2019)
Committee: Kathleen Gathercoal, Ph.D. (chair), Mary Peterson, Ph.D., Kristie Schmidlkofer, PsyD

MA

George Fox University, Newberg, OR
Masters of Arts in Clinical Psychology

April 2017

MA

LeTourneau University, Longview, TX
Masters of Arts in Marriage and Family therapy

April 2015

BA

University of Mary Hardin-Baylor, Belton, TX
Bachelors of Arts, Psychology Major

April 2013

Supervised Clinical Experience
National Psychology Training Consortium- Cascades Region Internship

June 2019-June 2020

Yakima, WA; APA Accredited Internship
Supervisors: David Bauman, Psy.D., Bridget Beachy, Psy.D., Ruth Olmer, Psy.D., Steven Olmer, Psy.D., Arissa
Walberg, Ph.D
Position title: Behavioral Health Consultant- Intern
Treatment setting: Rural medical clinic, pediatric clinic
Population: Low SES individuals, 0-65+ years old, LBGTQ+

● Provide brief group and individual evidence-based therapy (>4 visits, 20-30 minutes) at
a resident-training medical clinic, pediatric clinic, rural medical clinic, and LBGTQ+ youth
space. Additionally, conduct same-day appointments via warm-handoffs or cold-crashes
as needed.
● Develop a quality improvement project toward enhancing patient/provider experience
within a primary care setting. The project aim is to implement functional living
assessments and assess the utility of such testing in primary care.
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● Briefly consult with primary care providers regarding patient’s behavioral health and
other contextual concerns to ensure patients receive optimum care.
Evergreen Clinical Services

July 2018-May 2019

Portland, Or
Supervisors: Brian Goff, Ph.D.
Position title: Practicum Therapist
Treatment setting: Private Practice
Population: Low SES individuals, 18-65+ years old

● Provide Acceptance and Commitment Therapy in traditional 40-50 minute sessions.
● Charge patients a small fee per session and monitor patient balances.
Pre-internship, Assessment Clinic at the Behavioral Health Center

August 2018-Present

Newberg, Or
Supervisors: Glena Andrews, Ph.D
Position title: Student Assessment Specialist
Treatment setting: Community Mental Health
Population: Typically low SES individuals, 5-65+ years old

● Administer an array of psychodiagnostic, neuropsychological, and personality
assessments to answer referral questions from a variety of referral sources
● Write cohesive integrated reports utilizing data from multiple sources to offer
comprehensive answers to complex referral questions.
● Conduct 60-90 minute clinical interviews to gather relevant data that informs test
battery creation and test interpretation.
Practicum II, Portland VA Medical Center

July 2017-July 2018

Portland, Or
Supervisors: Jason Steward, Ph.D., Brett Fuller, Ph.D., Walter Winfree, Psy.D., Nina Hidalgo, Ph.D., Annette Tardif,
Ph.D., Drew Fowler, Ph.D., Marilyn Huckans, Ph.D..
Treatment setting: VA Hospital
Population: Veterans and family, 25-65+ years old

● Provide mental health services across a diverse span of needs within the following
rotations/departments: Outpatient Mental Health, Health Psychology, Palliative Care
(with NW Pain Clinic sub-rotation), Primary Care Mental Health Integration (PCMHI).
● Provide brief individual therapy (4+ visits for 60 minute sessions) using empirically
validated modalities toward treating mood and functioning concerns.
● Conduct psychodiagnostic assessments to clarify diagnostic questions from referring
providers and guide overall treatment. Referral questions included ADHD concerns,
sexual dysfunction, PTSD concerns, and other mood related difficulties.
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● Perform chronic pain assessments via intake/structured interview and provide
appropriate recommendations.
Practicum I, Physicians Medical Center

November 2016-July 2017

McMinnville, Or
Supervisor: Kristie Schmidlkofer, Psy.D.
Treatment setting: Integrated Health Care; rural medical clinic
Population: 3 years old to 65+, LBGTQ

● Work alongside physicians to provide an integrated medical care team for patients that
have behavioral and mental health concerns.
● Provide brief individual therapy (>4 visits for 20-30 minute sessions) using empirically
validated therapy modalities, including Motivational Interviewing, CBT, Acceptance and
Commitment Therapy.
● Conduct same-day appointments and warm handoffs from physicians for patients who
are experiencing acute crises.
● Assessment of ADHD, depression, anxiety and cognitive functioning.
Practicum I, Northwest ADHD Treatment Center

July 2016-September 2017
Tualatin, Or
Supervisor: Tim Neary, Psy.D.
Treatment Setting: Multidisciplinary Outpatient Mental Health and Psychiatric Clinic
Population: 18-64 years old

● Provide assessment, consultation, and brief behavioral interventions to patients with
attention related difficulties and other emotional concerns, such as anxiety, depression,
and PTSD.
● Administer the Test of Variables of Attentions (T.O.V.A.) and write succinct reports
integrating patient history to generate diagnoses and subsequent recommendations.
● Assess if patient is appropriate for medication management with on-site nurse
practitioners.
● Coordinate paperwork with insurance companies toward requesting psychological
testing for patients.
Pre-Practicum II, George Fox University

January 2016– May 2016

Newberg, Or
Supervisors: Glena Andrews, Ph.D., Shaun Davis, Psy.D.

•Provide outpatient individual psychotherapy services to volunteer young adult university
students; conduct intake interviews, prepare treatment plans, and generate fitting diagnostic
impressions.
• Create professional reports, present case conceptualizations.
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•Tape all sessions, review, and discuss them in individual and group supervision.
Treating Competition Anxiety in Collegiate Athletes, George Fox University Oct. 2015– May 2018
Newberg, OR

Supervisor: Glena Andrews, Ph.D.
Treatment Setting: College/University Counseling
Population: Undergraduate College Athletes, 18-22 years old

● Provide psychotherapy for collegiate student-athletes with an emphasis on measuring and
reducing pre-competition anxiety.
● Receive individual supervision on therapeutic alliance and intervention techniques used in
session.
Pre-Practicum I, George Fox University

September 2015 – December 2015

Newberg, OR
Supervisors: Glena Andrews, Ph.D., Shaun Davis, Psy.D.

● Learned psychotherapy skills at the graduate level with group and individual supervision.
These skills include intake interviews/reports, basic counseling skills, person-centered
conceptualization, conducting an MMSE, and learning the ORS/SRS.

Teaching Experience
Teacher Assistant for PsyD 512 Statistics
Fall 2018
Aid graduate level students in completing statistics-related coursework during class and outside of
predetermined class times.
Guest lecture for Psyc 150 General Psychology
Spring 2017
Deliver comprehensive lecture appropriate to introductory level psychology undergraduate students about the
brain with regard to structure and subsequent behavior.
Teacher Assistant for PsyD 552 Cognitive Behavioral Therapy
Demonstrate and guest lecture on schema therapy and ACT for graduate level students.

Fall 2017

Teacher Assistant for Psyc 382 Advanced Counseling Skills
Fall 2017, Fall 2018
Assess and monitor the ongoing development of undergraduate students’ counseling skills while utilizing
bidirectional feedback to maximize this process.

Relevant Work/Volunteer Experience
ACT For Business
October 2018-May 2019
Provide local businesses an overview of mindfulness and values guided decision making training designed to
increase what ACT calls “Psychological Flexibility”.
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● Conduct a one-hour presentation to the non-teaching/support staff of Tualatin
Independent School District during an in-service training day on October 12,2018.
● Guide participants in mindful eating exercise to encourage mindfulness
practices.
● Emphasize that the program is dedicated to healthier employees, not more
productive employees though increases in productivity often accompany
improvements in health.
● Provide multiple metaphors that capture the utility and essence of
mindfulness, such as “Leaves on a stream”.
Psychometrician for Dr. Gary Monkarsh’s, Ph.D., Private Practice
A private practice that specializes in ADHD and PTSD evaluations across the lifespan.

June 2018-Present

● Work with other colleagues and the owner of the practice to schedule patients
with limited space and time.
● Dictate test results and behavioral observations for a transcriptionist to type
and redirect to the licensed psychologist for writing purposes.
● Administer cognitive, achievement, attention, and malingering tests.
Friendsview Retirement Community
June 2016-January 2017
Volunteer at a retirement community for adults over 65 years old needing from little to constant care. Provides
technical support and engages in community-wide activities.

● Conduct interviews with residents and upload their stories to an archive for
residents’ family members to access.
● Plan a group for bereavement that enables residents to grieve loved ones and
process the transition into assisted living.
● Offer IT support to residents in the technology lab.
Mental-Health Technician at the Regional Crisis Response Center
May 2014 –May 2015
Provide specialized care for adults needing 24-hour inpatient psychiatric care offering psychiatric
interventions, medication stabilization, cognitive therapy, stress management, anxiety and depression
education, and group therapy. Located in Kilgore, TX. Supervisors: Jeffery Quiett Ph.D., Ashley Bing, M.A.

● Conduct intake screens according to protocol, uphold the therapeutic milieu, tend to client
comfort and transport, measure and report client’s vital signs, and maintain facility
cleanliness.
● Lead group therapy sessions about hope, depression, and bereavement.
● Consult with supervisors and members of a multidisciplinary clinical team that involved
nurses, physicians, psychiatrists, and psychologists.
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Dissertation
Studying the effectiveness of group therapy on chronic pain: A program evaluation
The study sought to evaluate the effectiveness of group therapy with respect to how it conducted at a
rural medical clinic in McMinville, Oregon. The preliminary defense of this proposal was conducted on
May 17, 2017. The final defense was conducted on May 8, 2019.

Invited Presentations
Meguro, L., Weeks, T., Summers, W., Roid, G., Bufford, R. (2018, May). Nonverbal cognitive assessment
for special-needs or non-English ADHD or LD cases. Poster presented at the Western Psychological
Association (WPA). Portland OR.
Summers, W. (2017, November). The effectiveness of the Pain Pathway at Physicians Medical Center:
A program evaluation. Presented at Pain Summit 4.0. McMinville, OR.
Summers, W., Wendler, D., Neary, T. (2017, January). A meta-analysis of ADHD and increased risk for
suicide. Poster presented at The American Professional Society of ADHD and Related Disorders
(APSARD). Washington, D.C..

Professional Affiliations
Collaborative Family Healthcare Assocation (CFHA)
Academic organization that seeks to stimulate the exchange of scientific and
Professional ideas for those interested in behavioral sciences.

2017- Present

Western Psychological Assocation (WPA)
Academic organization that seeks to stimulate the exchange of scientific and
Professional ideas for those interested in behavioral sciences.

2017- Present

Association of Contextual Behavioral Science (ACBS)
2017- Present
Professional organization that promotes online learning, in-person training opportunities
and research for clinicians interested in ACT, RFT, or contextual behavioral science.

American Psychological Association (Student Affiliate)

2013 - Present

Scientific and professional organization that represents psychologists in the USA

Other Affiliations
Gender, Sexuality, and Identity Student Interest Group

2015-2019

*Student leader (September 2016- May 2018)
PsyD student-led organization that discusses and researches human sexuality and gender identity
Geriatric Psychology Student Interest Group
2016- 2017
*Student leader/Founder (September 2016- May 2017)
PsyD student-led organization that investigates the aging process and overall experience of older adults.
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Selected Trainings and Workshops
Gender and Sexuality Certificate Course
Speaker: Brooke Kuhnhausen, Ph.D.
Site: George Fox University

October-December 2018

Spiritual Formation: Looking Closer at Soul-Care
Speaker: Mark McMinn, Ph.D., Lisa McMinn, Ph.D.
Site: George Fox University
Treating Complex Patients with Chronic Pain
Speakers: Nina Hidalgo, Ph.D.
Site: Portland VA Medical Center

September 2018

February 2018

Leadership Training: A seminar
Speaker: Mary Dunn, Ph.D.
Site: George Fox University

November 2017

Diversity and psychotherapy
Speakers: Jeff Sordahl, PsyD
Site: George Fox University

November 2017

Pain Summit 4.0- All About Opioids
Speakers: Bill Koenig, D.O., Representative Ron Noble,
Dwight Holton (former Attorney General), Kody Quinlan,
Mary Borges, Ph.D., Cory Bradly, Pharm.D., Will Summers, M.A.,
Site: Grand Ballroom, McMinville OR

November 2017

ACT II- Seattle
Speaker: Steve Hayes, Ph.D.
Site: Marriott Inn, Seattle WA

October 2017

Languages
● English
Proficiency
● Spanish
Proficiency

Native
Limited Working

